CD7 and in situ carcinoma: On the other hand, approximately 60% of CD7+ cells coexpressed the NK marker CD56 and the NK TF EOMES, leading to their identification as NK cells, although no marked differences were detected between control mucosa, LSIL, and CIS/IC samples (Figure 3, A and D, and data not shown).